在循环的自由DNA和匹配的转移性瘤中发生的基因组变化和转录性表型
Nobuyuki Takahashi1,2, Lorinc Pongor1, Shivam P Agrawal3
1Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA.
Genome medicine
|February 26, 2025
概括
在小细胞肺癌 (SCLC) 中循环无细胞DNA (cfDNA) 分析非侵入性地捕获瘤分子特征和演变. 这种基于等离子体的方法为指导SCLC治疗提供了组织活检的全面替代方案.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子诊断学 分子诊断
背景情况:
- 在癌症医学中,循环无细胞DNA (cfDNA) 分析至关重要.
- 需要将cfDNA与瘤活检进行比较,以便在潜在患者队列中阐明分子特征.
- 血cfDNA对小细胞肺癌 (SCLC) 治疗指导具有吸引力,这是由于活检的挑战.
研究的目的:
- 系统地比较cfDNA剖析与复发性SCLC中标准瘤活检的有效性.
- 评估cfDNA识别阻力机制和驱动器改变的能力.
- 评估cfDNA在追踪瘤演变和预测治疗反应方面的实用性.
主要方法:
- 对来自20名复发性SCLC患者的49个血样本的前性队列的分析.
- 低通全基因组测序 (0.1X) 的cfDNA.
- 与时间点匹配的瘤全外体 (130X) 和转录组测序进行比较.
主要成果:
- cfDNA反映了瘤突变和拷贝数的情况.
- cfDNA确定了瘤活检所遗漏的抵抗机制和驱动器变化.
- 纵向cfDNA分析可靠地跟踪了瘤反应,进展和克隆进化.
- cfDNA片段分析预测了SCLC的神经内分泌表型和治疗反应.
结论:
- cfDNA提供了关于SCLC瘤异质性和演变的全面,非侵入性视图.
- 这些发现支持SCLC患者的非侵入性分层.
- cfDNA分析为组织活检提供了一个有希望的替代方案,用于指导SCLC治疗.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Cancers Originate from Somatic Mutations in a Single Cell
11.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.4K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


